Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Mar. 06, 2024
Jun. 30, 2023
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2023      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2023      
Current Fiscal Year End Date --12-31      
Entity File Number 001-15771      
Entity Registrant Name ABEONA THERAPEUTICS INC.      
Entity Central Index Key 0000318306      
Entity Tax Identification Number 83-0221517      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One 6555 Carnegie Avenue      
Entity Address, Address Line Two 4th Floor      
Entity Address, City or Town Cleveland      
Entity Address, State or Province OH      
Entity Address, Postal Zip Code 44103      
City Area Code (646)      
Local Phone Number 813-4701      
Title of 12(b) Security Common Stock, $0.01 par value      
Trading Symbol ABEO      
Security Exchange Name NASDAQ      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 78,468,000
Entity Common Stock, Shares Outstanding     27,355,037  
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] true      
Document Financial Statement Restatement Recovery Analysis [Flag] false      
Auditor Firm ID 34 726    
Auditor Name Deloitte & Touche LLP WHITLEY PENN LLP    
Auditor Location Morristown, New Jersey Plano, Texas